The inhibition of cDC1 development by breast cancers is due to their production of G-CSF, a STAT3-activating cytokine [36]; consistent with these prior studies, we found PyMT tumor cells secrete G-CSF in culture. The gene discussed is CSF3; the disease is breast carcinoma.